Search research articles
Contact Us
Filters
Showing results (41-50 of 52) with videos related to
Page
of 6
Sort By:
Scientific Reports
|
January 9, 2014
A novel efficient feeder-free culture system for the derivation of human induced pluripotent stem cells
Masato Nakagawa, Yukimasa Taniguchi, Sho Senda, et al.
Nature
|
September 1, 2017
Human iPS cell-derived dopaminergic neurons function in a primate Parkinson's disease model
Tetsuhiro Kikuchi, Asuka Morizane, Daisuke Doi, et al.
Nature Methods
|
April 5, 2011
A more efficient method to generate integration-free human iPS cells
Keisuke Okita, Yasuko Matsumura, Yoshiko Sato, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 22, 2013
Differentiation-defective phenotypes revealed by large-scale analyses of human pluripotent stem cells
Michiyo Koyanagi-Aoi, Mari Ohnuki, Kazutoshi Takahashi, et al.
Stem Cells (Dayton, Ohio)
|
February 14, 2012
Prolonged maturation culture favors a reduction in the tumorigenicity and the dopaminergic function of human ESC-derived neural cells in a primate model of Parkinson's disease
Daisuke Doi, Asuka Morizane, Tetsuhiro Kikuchi, et al.
Nature Communications
|
September 1, 2017
MHC matching improves engraftment of iPSC-derived neurons in non-human primates
Asuka Morizane, Tetsuhiro Kikuchi, Takuya Hayashi, et al.
The Journal of Clinical Investigation
|
January 5, 2005
Dopaminergic neurons generated from monkey embryonic stem cells function in a Parkinson primate model
Yasushi Takagi, Jun Takahashi, Hidemoto Saiki, et al.
Stem Cells (Dayton, Ohio)
|
March 25, 2006
Transplantation of human embryonic stem cell-derived cells to a rat model of Parkinson's disease: effect of in vitro differentiation on graft survival and teratoma formation
Anke Brederlau, Ana Sofia Correia, Sergey V Anisimov, et al.
Cell Stem Cell
|
August 20, 2025
Control of immune response in an iPSC-based allogeneic cell therapy clinical trial for Parkinson's disease
Asuka Morizane, Emi Yamasaki, Takero Shindo, et al.
Nature
|
April 16, 2025
Phase I/II trial of iPS-cell-derived dopaminergic cells for Parkinson's disease
Nobukatsu Sawamoto, Daisuke Doi, Etsuro Nakanishi, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 52) with videos related to
Sort By:
Page
of 6
Scientific Reports
|
January 9, 2014
A novel efficient feeder-free culture system for the derivation of human induced pluripotent stem cells
Masato Nakagawa, Yukimasa Taniguchi, Sho Senda, et al.
Nature
|
September 1, 2017
Human iPS cell-derived dopaminergic neurons function in a primate Parkinson's disease model
Tetsuhiro Kikuchi, Asuka Morizane, Daisuke Doi, et al.
Nature Methods
|
April 5, 2011
A more efficient method to generate integration-free human iPS cells
Keisuke Okita, Yasuko Matsumura, Yoshiko Sato, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 22, 2013
Differentiation-defective phenotypes revealed by large-scale analyses of human pluripotent stem cells
Michiyo Koyanagi-Aoi, Mari Ohnuki, Kazutoshi Takahashi, et al.
Stem Cells (Dayton, Ohio)
|
February 14, 2012
Prolonged maturation culture favors a reduction in the tumorigenicity and the dopaminergic function of human ESC-derived neural cells in a primate model of Parkinson's disease
Daisuke Doi, Asuka Morizane, Tetsuhiro Kikuchi, et al.
Nature Communications
|
September 1, 2017
MHC matching improves engraftment of iPSC-derived neurons in non-human primates
Asuka Morizane, Tetsuhiro Kikuchi, Takuya Hayashi, et al.
The Journal of Clinical Investigation
|
January 5, 2005
Dopaminergic neurons generated from monkey embryonic stem cells function in a Parkinson primate model
Yasushi Takagi, Jun Takahashi, Hidemoto Saiki, et al.
Stem Cells (Dayton, Ohio)
|
March 25, 2006
Transplantation of human embryonic stem cell-derived cells to a rat model of Parkinson's disease: effect of in vitro differentiation on graft survival and teratoma formation
Anke Brederlau, Ana Sofia Correia, Sergey V Anisimov, et al.
Cell Stem Cell
|
August 20, 2025
Control of immune response in an iPSC-based allogeneic cell therapy clinical trial for Parkinson's disease
Asuka Morizane, Emi Yamasaki, Takero Shindo, et al.
Nature
|
April 16, 2025
Phase I/II trial of iPS-cell-derived dopaminergic cells for Parkinson's disease
Nobukatsu Sawamoto, Daisuke Doi, Etsuro Nakanishi, et al.
Page
of 6